Regeneron Pharmaceuticals, Inc.?is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Regeneron markets three products in?the United States, EYLEA??(aflibercept) Injection, ZALTRAP??(ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST??(rilonacept) Injection for Subcutaneous Use; ZALTRAP is co-commercialized with Sanofi. ?Phase III studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727. ?Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.
777 Old Saw Mill River Rd